Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

OACCW

Oaktree Acquisition Corp. III Life Sciences

CIK 0002029769 · Nasdaq

NasdaqFinancialsBlank Checks
$0.95
↑ 0.02 (2.55%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$0.00
P/E Ratio
0.00
EPS
Not covered
Dividend Yield
Not covered
52W Position
35%
Beta
0.08

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.00
P/S
Not covered
EV/Revenue
Not covered
ROE
-97.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 35%
$0.50$1.79

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
$7.29M
Total Assets
$203.11M
Free Cash Flow
–

Recent news